2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg)

By DCC Coin

$125.00 USD — In Stock

2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg)

Description

Product: 2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg) Product Overview: 2X Blend CJC-1295 Without DAC / Ipamorelin is a combination of two synthetic peptides frequently studied for their potential roles in growth hormone (GH) pathway signaling. CJC-1295 Without DAC is a modified analog of growth hormone-releasing hormone (GHRH) designed to improve stability and receptor interaction in research settings. Ipamorelin, a selective pentapeptide, has been investigated for its ability to interact with the ghrelin receptor (GHS-R1a) and its potential to influence GH release. This blend provides 5mg of each peptide per vial, supporting studies into their combined effects on GH-related processes. Research Profile: This peptide blend has been investigated in preclinical models to explore its potential effects on growth hormone secretion and related physiological pathways. Research areas include: - Growth Hormone Release: Studies have examined the ability of CJC-1295 Without DAC to interact with GHRH receptors and Ipamorelin to selectively engage ghrelin receptors, potentially influencing GH secretion. - Pituitary Function: Research has focused on how this combination may affect the anterior pituitary gland's GH synthesis and release, including receptor binding and downstream signaling pathways. - Metabolic Regulation: Preliminary studies have explored the blend's potential involvement in glucose metabolism and lipid regulation through GH-mediated mechanisms. - Cellular Growth and Repair: Laboratory models have investigated the peptides' potential effects on cellular growth factors and protein synthesis, particularly in muscle and connective tissues. - Synergistic Effects: Research has assessed the combined action of CJC-1295 Without DAC and Ipamorelin, focusing on their complementary mechanisms in modulating GH secretion dynamics. Key Research Applications: This blend has been utilized in preclinical research to investigate: - Endocrine Function: Studies into the roles of GHRH and ghrelin receptor pathways in GH regulation. - Muscle Physiology: Research into GH-associated protein synthesis and muscle cell hypertrophy in controlled experimental conditions. - Energy Homeostasis: Investigations into the peptides' potential effects on energy utilization and metabolic processes via GH pathways. - Tissue Regeneration: Studies examining the role of GH in cellular repair and tissue recovery in laboratory models. Specifications: Peptide Content: 10mg per vial (5mg CJC-1295 Without DAC, 5mg Ipamorelin) Appearance: Lyophilized powder Storage & Handling: Store in a cool, dry environment protected from light and moisture. Reconstitution and handling should be performed using standard laboratory procedures and appropriate laboratory controls.

Research Summary

A two-peptide formulation used in laboratory studies of GHRH- and ghrelin-receptor signaling and pituitary secretory dynamics.

Back to shop